Added to YB: 2026-04-22
Pitch date: 2026-04-20
ARX.AX [neutral]
Aroa Biosurgery Limited
-3.77%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
Market Cap
AUD 221.0M
Pitch Price
AUD 0.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
40.62
P/E
-120.39
EV/Sales
2.26
Sector
Biotechnology
Category
value
Monday Delight: 20/04/2026 - Aroa Biosurgery Limited
ARX.AX (quick overview): Medical tech co developing soft tissue repair products; 85% gross margin, recently FCF breakeven. Trading 2.2x EV/sales vs peer PolyNovo at 5x+ (>100% discount). Strong wound care outcomes driving growth via expanding US sales force. At 25% op margin assumption, trades ~9x EV/EBIT. Recurring revenue model tied to surgical procedures & chronic wound treatment.
Read full article (1 min)